Clinical Research Directory
Browse clinical research sites, groups, and studies.
LALUCA Research Platform A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice
Sponsor: Karl Landsteiner Institute for Lung Research and Pneumological Oncology
Summary
This is a prospective analysis of the diagnosis and treatment of lung cancer in a real-world setting. The aim of the project is to establish a clinical platform to collect representative data on molecular testing, sequence of systemic tumor therapy and other therapies, and disease progression of patients with lung cancer. A special focus will be on molecular biomarker testing and reflex NGS testing. Another aim of the registry is the collection of quality indicators in lung cancer care. The results of the register will be used to describe the current state of care and to develop it further for the future.
Official title: Landsteiner Lung Cancer Research Platform (LALUCA) A Prospective Analysis of Lung Cancer Diagnosis and Management in Clinical Practice
Key Details
Gender
All
Age Range
18 Years - 125 Years
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2020-04-17
Completion Date
2030-04
Last Updated
2024-03-18
Healthy Volunteers
No
Conditions
Locations (1)
Karl Landsteiner Institut für Lungenforschung und Pneumologische Onkologie
Vienna, Austria